Related references
Note: Only part of the references are listed.Biomarker identification and pathway analysis by serum metabolomics of childhood acute lymphoblastic leukemia
Yunnuo Bai et al.
CLINICA CHIMICA ACTA (2014)
The differential metabolite profiles of acute lymphoblastic leukaemic patients treated with 6-mercaptopurine using untargeted metabolomics approach
Z. Bannur et al.
CLINICAL BIOCHEMISTRY (2014)
shRNA-mediated GSTP1 gene silencing enhances androgen-independent cell line DU145 chemosensitivity
Peng Jin et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2014)
Nitric Oxide (NO) Releasing Poly ADP-ribose Polymerase 1 (PARP-1) Inhibitors Targeted to Glutathione S-Transferase P1-Overexpressing Cancer Cells
Anna E. Maciag et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Association between GSTP1 Ile105Val polymorphism and glioma risk: A systematic review and meta-analysis
Peng Xie et al.
TUMOR BIOLOGY (2014)
Mass spectrometry-based serum peptide profiling in hepatocellular carcinoma with bone metastasis
Jian He et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Glutathione S-transferase P1 mRNA expression in plasma cell disorders and its correlation with polymorphic variants and clinical outcome
Flavia Stella et al.
CANCER EPIDEMIOLOGY (2013)
Identification of tubulin beta chain, thymosin beta-4-like protein 3, and cytochrome b-c1 complex subunit 1 as serological diagnostic biomarkers of gastric cancer
Nai-Jun Fan et al.
CLINICAL BIOCHEMISTRY (2013)
GSTP1 Ile105Val polymorphism and colorectal cancer risk: An updated analysis
Zhibo Tan et al.
GENE (2013)
The GSTP1 A1578G polymorphism and the risk of childhood acute lymphoblastic leukemia: results from an updated meta-analysis
G. Z. Huang et al.
GENETICS AND MOLECULAR RESEARCH (2013)
High preoperative plasma fibrinogen is an independent predictor of distant metastasis and poor prognosis in renal cell carcinoma
Jun Du et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2013)
Tubulin Beta Chain, Filamin A Alpha Isoform 1, and Cytochrome b-c1 Complex Subunit 1 As Serological Diagnostic Biomarkers of Esophageal Squamous Cell Carcinoma: A Proteomics Study
Nai-Jun Fan et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2013)
GSTP1 Ile105Val Polymorphism and Prostate Cancer Risk: Evidence from a Meta-Analysis
Bingbing Wei et al.
PLOS ONE (2013)
Identification of Kininogen-1 as a Serum Biomarker for the Early Detection of Advanced Colorectal Adenoma and Colorectal Cancer
Jing Wang et al.
PLOS ONE (2013)
Metabolomics of the Tumor Microenvironment in Pediatric Acute Lymphoblastic Leukemia
Stefano Tiziani et al.
PLOS ONE (2013)
Has MRD monitoring superseded other prognostic factors in adult ALL?
Monika Brueggemann et al.
BLOOD (2012)
Detection of serum tumor markers in multiple myeloma using the CLINPROT system
Aili He et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2012)
Identifying FGA Peptides as Nasopharyngeal Carcinoma-Associated Biomarkers by Magnetic Beads
Ya-Lan Tao et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Defining the correct role of minimal residual disease tests in the management of acute lymphoblastic leukaemia
Giovanni Cazzaniga et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Quantitative assessment of MLAA-34 expression in diagnosis and prognosis of acute monocytic leukemia
Jianqiang Zhao et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Advances in acute lymphoblastic leukemia in adults
Josep-Maria Ribera
CURRENT OPINION IN ONCOLOGY (2011)
The role of glutathione S-transferase P in signaling pathways and S-glutathionylation in cancer
Kenneth D. Tew et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Very early/early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatment
C. Eckert et al.
LEUKEMIA (2011)
Acute lymphoblastic leukemia in adults
Josep-Maria Ribera
PEDIATRIC REPORTS (2011)
The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial
V. Seebacher et al.
BRITISH JOURNAL OF CANCER (2010)
Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993
Bella Patel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Adult Acute Lymphoblastic Leukemia Concepts and Strategies
Stefan Faderl et al.
CANCER (2010)
Prognostic significance of preoperative plasma fibrinogen in endometrial cancer
Fabio Ghezzi et al.
GYNECOLOGIC ONCOLOGY (2010)
Cancer-specific MALDI-TOF profiles of blood serum and plasma: Biological meaning and perspectives
M. A. Karpova et al.
JOURNAL OF PROTEOMICS (2010)
Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008
M. Brueggemann et al.
LEUKEMIA (2010)
Minimal Residual Disease in Acute Lymphoblastic Leukemia
Dario Campana
HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM (2010)
Fibrinogen plasma levels are an independent prognostic parameter in patients with cervical cancer
Stephan Polterauer et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2009)
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
Renato Bassan et al.
BLOOD (2009)
Optimization of magnetic beads for maldi-TOF MS analysis
Feng Qiu
Frontiers in Bioscience-Landmark (2009)
Elevated Levels of Plasma Fibrinogen in Patients With Pancreatic Cancer Possible Role of a Distant Metastasis Predictor
Qingqu Guo et al.
PANCREAS (2009)
Platelet factor-4 is an indicator of blood count recovery in acute myeloid leukemia patients in complete remission
Jin Young Kim et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
Non-specific amplification of patient-specific Ig/TCR gene rearrangements depends on the time point during therapy: implications for minimal residual disease monitoring
V. H. J. van der Velden et al.
LEUKEMIA (2008)
Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus
Hiroya Takeuchi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease
Manuel Aivado et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome
Glen L. Hortin
CLINICAL CHEMISTRY (2006)
Proteomic-based prediction of clinical behavior in adult acute lymphoblastic leukemia
M Albitar et al.
CANCER (2006)
Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia
M Brüggemann et al.
BLOOD (2006)
Differential exoprotease activities confer tumor-specific serum peptidome patterns
J Villanueva et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology
AJ Cheng et al.
CLINICAL CHEMISTRY (2005)
Decreased levels of CXC-chemokines in serum of benzene-exposed workers identified by array-based proteomics
R Vermeulen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Adult acute lymphoblastic leukaemia
R Bassan et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2004)
Use of proteomic patterns in serum to identify ovarian cancer
EF Petricoin et al.
LANCET (2002)
Share Paper
